3 Depressed Biotechs that Investors with a Long-Term Perspective Should Buy Right Now Post author:Sam Post published:April 11, 2016 Post category:BioPharma April 11, 2016By Alex Keown… Source: BioSpace You Might Also Like Mysterious Moderna Hints at Its IPO Timeline November 2, 2017 DNAnexus Announces Two Key Executive Appointments March 15, 2017 Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017
Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017
